Emergent BioSolutions Inc
NYSE:EBS

  • LAST PRICE
    6.5000
  • TODAY'S CHANGE (%)
    -0.3900 (-5.6604%)
  • Bid / Lots
    6.5000/ 11
  • Ask / Lots
    6.5100/ 9
  • Open / Previous Close
    6.8300 / 6.8900
  • Day Range
    6.2850
    7.1799
  • 52 Week Range
    1.4200
    9.6600
  • Volume
    1,459,065

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Pharmaceuticals - Diversified Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
EBS
Emergent BioSolutions Inc
361.0M
-0.6x
---
PCRX
Pacira Biosciences Inc
1.3B
21.1x
---
SNDL
SNDL Inc
486.3M
-5.0x
---
TLRY
Tilray Brands Inc
1.3B
-3.4x
---
COLL
Collegium Pharmaceutical Inc
1.0B
15.3x
---
PBH
Prestige Consumer Healthcare Inc
3.4B
16.5x
---
As of 2024-06-26

Company Information

Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a Bioservices portfolio. Its segments include Commercial Products, MCM Products, and Services Segment. Commercial Products segment include NARCAN (naloxone HCl). MCM Products segment consists of its Anthrax - MCM, Smallpox - MCM and Other Products. Services segment consisting of its Bioservices offerings. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and/or central nervous system depression. Its portfolio of Bioservices consists of three but interrelated service pillars, such as development services (process and analytical development) and drug substance manufacturing.

Contact Information

Headquarters
300 Professional DrGAITHERSBURG, MD, United States 20879
Phone
240-631-3200
Fax
240-631-3203

Executives

Independent Chairman of the Board
Zsolt Harsanyi
President, Chief Executive Officer, Director
Joseph Papa
Chief Financial Officer, Executive Vice President, Treasurer
Richard Lindahl
Executive Vice President - External Affairs, General Counsel, Corporate Secretary
Jennifer Fox
Executive Vice President - Quality and Ethics and Compliance
Coleen Glessner

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$361.0M
Revenue (TTM)
$1.2B
Shares Outstanding
52.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.62
EPS
$-10.87
Book Value
$12.44
P/E Ratio
-0.6x
Price/Sales (TTM)
0.3
Price/Cash Flow (TTM)
---
Operating Margin
-39.21%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.